In a mouse model of PD, metformin significantly delays astrocyte senescence and improves neurodegeneration by reducing mtDNA release through mitofusin 2 and suppressing the cGAS-STING signaling pathway [384]. This evidence concerns the gene CGAS and Parkinson disease.